Showing 1341 - 1350 of 1359 for "ITC litigation" with applied filters
16 May 2019 by
Paul A Ainsworth and Lauren A Watt of Sterne Kessler Goldstein & Fox examine the extent to which the proposed Biologic Patent Transparency Act will reduce patent thickets, increase transparency and competition in the biologics industry.
12 December 2018 by
Managing IP is delighted to announce the launch of its official Rising Stars publication
13 November 2018 by
Firm gains post-grant proceedings specialist in Orange County
31 October 2018 by
This roundup includes Nelson Mullins Broad and Cassel, Kilpatrick Townsend & Stockton, Venable, Kacvinsky Daisak Bluni, Oblon, Shearman & Sterling, Alessandri, Maucher Jenkins, Hoyng Rokh Monegier, AWA, Venner Shipley, Mewburn Ellis, Page White and Farrer, Bird & Bird, Dittmar & Indrenius, Mathys & Squire, Baker McKenzie Habib Al Mulla, and Simone Intellectual Property Services Asia (SIPS).
21 September 2018 by
Managing Intellectual Property hosted a well-attended webinar yesterday to provide information about IP STARS and the research for the 2019 edition. Questions from attendees were also answered.
01 September 2018 by
At last, Germany has clear guidelines regarding the litigation value of an appeal to the German Federal High Court of Justice (BGH)
01 September 2018 by
In a judgment dated July 12 2018, the Delhi High Court has allowed a plea of patent infringement by Koninklijke Philips Electronics (Phillips)
01 September 2018 by
The Japanese IP system has vulnerable evidence collection procedures in comparison with foreign countries.
02 July 2018 by
At the end of April 2018, Advocate General (AG) Wathelet handed down an advisory opinion regarding the first of three recent referrals to the CJEU (C-121/17). This concerns the interpretation of Article 3(a) of Regulation (EC) No 469/2009.
02 July 2018 by
Shionogi is the owner of a patent entitled Pyrimidine Derivatives (JP2648897). X filed a request for a trial for invalidation of the patent. Nippon Chemiphar intervened in the trial as a plaintiff, and AstraZeneca UK intervened in the trial in order to support the defendant.